Avantor (AVTR) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, Avantor, Inc. (AVTR) reported revenue of $1.68 billion, down 1.1% over the same period last year. EPS came in at $0.24, compared to $0.25 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $1.68 billion, representing a surprise of +0.38%. The company delivered an EPS surprise of -4%, with the consensus EPS estimate being $0.25.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Avantor performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenue- Bioscience Production: $561.3 million versus $568.43 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +2.6% change.Revenue- Laboratory Solutions: $1.12 billion compared to the $1.11 billion average estimate based on four analysts. The reported number represents a change of -2.9% year over year.Adjusted Operating Income- Laboratory Solutions: $133.3 million versus the two-analyst average estimate of $144.2 million.Adjusted Operating Income- Corporate: $-20.8 million versus the two-analyst average estimate of $-17.99 million.Adjusted Operating Income- Bioscience Production: $139.7 million versus $134.75 million estimated by two analysts on average.View all Key Company Metrics for Avantor here>>>Shares of Avantor have returned -3.2% over the past month versus the Zacks S&P 500 composite's +2.3% change. The stock currently has a Zacks Rank #5 (Strong Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Avantor, Inc. (AVTR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks